DK0801571T3 - Opløselige 2'-chlor-2'-deoxyadenosion-formuleringer - Google Patents

Opløselige 2'-chlor-2'-deoxyadenosion-formuleringer

Info

Publication number
DK0801571T3
DK0801571T3 DK95943134T DK95943134T DK0801571T3 DK 0801571 T3 DK0801571 T3 DK 0801571T3 DK 95943134 T DK95943134 T DK 95943134T DK 95943134 T DK95943134 T DK 95943134T DK 0801571 T3 DK0801571 T3 DK 0801571T3
Authority
DK
Denmark
Prior art keywords
formulations
deoxyadenosion
chloro
soluble
cda
Prior art date
Application number
DK95943134T
Other languages
English (en)
Inventor
Michael Bornstein
Rosemary Rozman
Kevin Francis Long
George Kaon Wong
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Application granted granted Critical
Publication of DK0801571T3 publication Critical patent/DK0801571T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK95943134T 1994-12-22 1995-12-15 Opløselige 2'-chlor-2'-deoxyadenosion-formuleringer DK0801571T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36208394A 1994-12-22 1994-12-22
PCT/US1995/016418 WO1996019230A1 (en) 1994-12-22 1995-12-15 Soluble 2-chloro-2'-deoxyadenosine formulations

Publications (1)

Publication Number Publication Date
DK0801571T3 true DK0801571T3 (da) 2003-01-06

Family

ID=23424634

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95943134T DK0801571T3 (da) 1994-12-22 1995-12-15 Opløselige 2'-chlor-2'-deoxyadenosion-formuleringer

Country Status (15)

Country Link
US (1) US5681822A (da)
EP (1) EP0801571B1 (da)
JP (1) JPH10512549A (da)
AT (1) ATE223221T1 (da)
CA (1) CA2208484C (da)
CZ (1) CZ194297A3 (da)
DE (1) DE69528080T2 (da)
DK (1) DK0801571T3 (da)
ES (1) ES2182920T3 (da)
HU (1) HUT77928A (da)
IL (1) IL116469A0 (da)
PL (1) PL321431A1 (da)
PT (1) PT801571E (da)
WO (1) WO1996019230A1 (da)
ZA (1) ZA9510924B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030166525A1 (en) * 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
US6194395B1 (en) * 1999-02-25 2001-02-27 Orthro-Mcneil Pharmaceutical, Inc. Cyclodextrin cladribine formulations
ATE492292T2 (de) * 2003-04-02 2011-01-15 Ares Trading Sa Flüssige oder gefriergetrocknete pharmazeutische zusammensetzung enthaltend fsh und/oder lh, das nichtionische tensid poloxamer 188 und ein antibakterielles mittel
EP1638595B1 (en) * 2003-06-20 2013-03-20 Ares Trading S.A. Freeze-dried fsh / lh formulations
FR2873695A1 (fr) * 2004-07-30 2006-02-03 Palumed Sa Molecules hybrides qa ou q est une aminoquinoleine et a est un antibiotique ou un inhibiteur de resistance), leur synthese et leurs utilisations en tant qu'agent antibacterien
EP4070800A1 (en) 2004-12-22 2022-10-12 Merck Serono S.A. Cladribine regimen for treating multiple sclerosis
AU2007253254B2 (en) 2006-05-24 2013-01-17 Merck Serono Sa Cladribine regimen for treating multiple sclerosis
EP2343074A1 (en) 2009-12-23 2011-07-13 Merck Serono S.A. Use of purine analogues for treating airway diseases
WO2019101960A1 (en) 2017-11-24 2019-05-31 Merck Patent Gmbh Cladribine regimen for use intreating progressive forms of multiple sclerosis
CA3194812A1 (en) 2020-09-10 2022-03-17 Merck Patent Gmbh Novel treatment regimen for the treatment of autoimmune disorders
IL305567A (en) 2021-03-03 2023-10-01 Ares Trading Sa A method for predicting the response of a patient treated with Cladribine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826823A (en) * 1985-02-05 1989-05-02 Warner-Lambert Company Methods of using 2-chloro-2'-deoxyadenosine-5'-phosphate and its salts
US4719295A (en) * 1985-12-31 1988-01-12 Warner-Lambert Company Compound 2-iodo-2'-deoxyadenosine
US5310732A (en) * 1986-02-03 1994-05-10 The Scripps Research Institute 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis
US4908441A (en) * 1988-07-19 1990-03-13 Warner-Lambert Company Deoxyadenosine compounds and methods of making and using the same
US5208327A (en) * 1991-12-18 1993-05-04 Ortho Pharmaceutical Corporation Intermediates useful in a synthesis of 2-chloro-2'-deoxyadenosine
AU678557B2 (en) * 1992-05-19 1997-06-05 Scripps Research Institute, The Use of 2-halo adenine derivatives as therapeutic agents against chronic myelogenous leukemia

Also Published As

Publication number Publication date
DE69528080T2 (de) 2003-06-05
EP0801571A1 (en) 1997-10-22
PL321431A1 (en) 1997-12-08
WO1996019230A1 (en) 1996-06-27
EP0801571B1 (en) 2002-09-04
DE69528080D1 (de) 2002-10-10
CZ194297A3 (en) 1997-10-15
ES2182920T3 (es) 2003-03-16
US5681822A (en) 1997-10-28
HUT77928A (hu) 1998-11-30
ZA9510924B (en) 1997-06-23
PT801571E (pt) 2002-12-31
JPH10512549A (ja) 1998-12-02
IL116469A0 (en) 1996-03-31
ATE223221T1 (de) 2002-09-15
CA2208484C (en) 2008-09-23
CA2208484A1 (en) 1996-06-27

Similar Documents

Publication Publication Date Title
HK1026363A1 (en) Ophthalmic compositions including glycerin and propylene glycol
PT799046E (pt) Solucoes estaveis de 2-cloro-2'-desoxiadenosina
FI933740A0 (fi) Peg-interferonkonjugat
ITRM920476A1 (it) Formulazioni galeniche contenenti ciclosporina.
MY131095A (en) Polyethylene protein conjugates.
AU6628496A (en) Polyether block copolymer micellar compositions for targeting biological agents
BR9713866A (pt) Composição farmacéutica
FI972514A (fi) Kasvainspesifisten sytotoksisten T-solujen in vivo aktivointi
PT932397E (pt) Formulacoes em aerossol medicinais compreendendo budesonida
TR199600499A2 (tr) S(+)-Etodolak'in oral formülasyonlari.
DK0801571T3 (da) Opløselige 2'-chlor-2'-deoxyadenosion-formuleringer
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
JO1907B1 (en) Dissolved compounds of 2-chloro-2-dioxin adenosine
DE69813165D1 (de) Hautdepigmentierungsmittel
JO1908B1 (en) Static compounds of 2-chloro-2-dioxin adenosine
IT1254452B (it) N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli
DE69822098D1 (de) Sonnenschutzmittel die beschädigte rns fragmente enthälten
CA2208241A1 (en) Stable solutions of 2-chloro-2'-deoxyadenosine formulations
McPhee The voices of young people: Being heard in our high schools
DE29617001U1 (de) Tablette in Herzform
RU96103721A (ru) Антгельминтное средство
MA22854A1 (fr) Conjugues de proteine et de polyethylene glycol .
KR970056462U (ko) 앞.뒤로 신을 수 있는 슬리퍼
IT1288577B1 (it) Struttura di supporto, in particolare composita da attacchi per monosci
ES1036308Y (es) Telefono movil integrado en el frontal extraible del auto-radio.